News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,875 Results
Type
Article (87861)
Company Profile (824)
Press Release (780175)
Multimedia
Podcasts (190)
Webinars (28)
Section
Business (233208)
Career Advice (4144)
Deals (39861)
Drug Delivery (145)
Drug Development (91392)
Employer Resources (203)
FDA (18374)
Job Trends (17416)
News (397811)
Policy (39956)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (179)
Alzheimer's disease (1778)
Antibody-drug conjugate (ADC) (332)
Approvals (18535)
Artificial intelligence (604)
Autoimmune disease (151)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (158)
Brain cancer (63)
Breast cancer (641)
Cancer (4881)
Cardiovascular disease (429)
Career advice (3566)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (809)
Cervical cancer (37)
Clinical research (76849)
Collaboration (1721)
Company closure (5)
Compensation (1115)
Complete response letters (70)
COVID-19 (2985)
CRISPR (95)
C-suite (814)
Cystic fibrosis (154)
Data (6106)
Decentralized trials (2)
Denatured (70)
Depression (142)
Diabetes (521)
Diagnostics (7203)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (292)
Drug pricing (214)
Drug shortages (36)
Duchenne muscular dystrophy (232)
Earnings (100005)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134910)
Executive appointments (1022)
FDA (21414)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (24)
Funding (1513)
Gene editing (209)
Generative AI (62)
Gene therapy (655)
GLP-1 (1104)
Government (5431)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (58)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (286)
Immuno-oncology (49)
Indications (81)
Infectious disease (3266)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (234)
Interviews (816)
IPO (17951)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (665)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (804)
MASH (171)
Medical device (14997)
Medtech (15041)
Mergers & acquisitions (22938)
Metabolic disorders (1353)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (337)
Neuropsychiatric disorders (92)
Neuroscience (3052)
NextGen: Class of 2026 (7706)
Non-profit (5107)
Now hiring (62)
Obesity (650)
Opinion (330)
Ovarian cancer (161)
Pain (198)
Pancreatic cancer (221)
Parkinson's disease (288)
Partnered (38)
Patents (486)
Patient recruitment (449)
Peanut (60)
People (66788)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23752)
Phase II (33343)
Phase III (25139)
Pipeline (4556)
Policy (327)
Postmarket research (3554)
Preclinical (10679)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (297)
Rare diseases (853)
Real estate (7437)
Recruiting (80)
Regulatory (28814)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (18)
RSV (82)
Schizophrenia (157)
Series A (253)
Series B (189)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (97)
The Weekly (118)
Vaccines (1124)
Venture capital (91)
Weight loss (447)
Women's health (83)
Worklife (21)
Date
Today (232)
Last 7 days (998)
Last 30 days (2101)
Last 365 days (33405)
2026 (1186)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1289)
Alabama (87)
Alaska (7)
Arizona (337)
Arkansas (14)
Asia (51466)
Australia (9032)
California (11239)
Canada (3241)
China (1121)
Colorado (473)
Connecticut (489)
Delaware (339)
Europe (118256)
Florida (1649)
Georgia (356)
Hawaii (3)
Idaho (68)
Illinois (932)
India (64)
Indiana (532)
Iowa (23)
Japan (410)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1436)
Massachusetts (8328)
Michigan (348)
Minnesota (646)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (83)
New Jersey (3052)
New Mexico (33)
New York (2984)
North Carolina (1576)
North Dakota (10)
Northern California (5348)
Ohio (343)
Oklahoma (22)
Oregon (54)
Pennsylvania (2260)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4326)
Tennessee (172)
Texas (1774)
United States (40730)
Utah (335)
Vermont (1)
Virginia (280)
Washington D.C. (85)
Washington State (945)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 868,875 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
AbbVie Bets Nearly $5B on RemeGen To Vie for Position in Hot Bispecific Market
The deal, which sees AbbVie paying RemeGen $650 million upfront, gives the pharma ex-China rights to the biotech’s PD-1/VEGF bispecific antibody—a modality being targeted by companies including BMS, Merck and Pfizer.
January 12, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
OS Therapies Enters into Warrant Inducement Agreements
January 12, 2026
·
7 min read
Press Releases
DaCapo Brainscience Appoints Leslie Williams as President & Chief Executive Officer; Announces Mridul Mehta, PhD, as Chief Technology Officer and Promotes Warren Hirst, PhD, to Chief Scientific Officer
January 12, 2026
·
1 min read
Press Releases
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
January 12, 2026
·
13 min read
Press Releases
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
January 12, 2026
·
1 min read
Press Releases
New targeted treatment offers hope for people with myelofibrosis
January 12, 2026
·
1 min read
Business
Moderna Hits 2025 Revenue Goal as Operating Costs Fall Faster than Forecast
While Moderna’s full-year sales landed in the upper end of its target range, Jefferies analysts said further reductions are needed if the biotech hopes to hit its 2028 break-even target.
January 12, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Incentive scheme for rare disease drug development vital for sector, says leading biotech
January 12, 2026
·
1 min read
Press Releases
Bio-Sourcing and Zerion Pharma join forces to develop first HER2 oral monoclonal antibody against breast cancer
January 12, 2026
·
1 min read
Press Releases
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
January 12, 2026
·
2 min read
1 of 86,888
Next
